Boxer Capital as of June 30, 2023
Portfolio Holdings for Boxer Capital
Boxer Capital holds 79 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Cl A | 6.8 | $146M | 1.4M | 101.96 | |
| Apellis Pharmaceuticals (APLS) | 6.7 | $144M | 1.6M | 91.10 | |
| Revolution Medicines (RVMD) | 5.8 | $125M | 4.7M | 26.75 | |
| Tyra Biosciences (TYRA) | 5.1 | $110M | 6.4M | 17.03 | |
| Springworks Therapeutics (SWTX) | 4.2 | $90M | 3.4M | 26.22 | |
| BeiGene Sponsored Adr (ONC) | 4.1 | $89M | 500k | 178.30 | |
| Akero Therapeutics (AKRO) | 3.6 | $78M | 1.7M | 46.69 | |
| Mirati Therapeutics | 3.4 | $72M | 2.0M | 36.13 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $69M | 600k | 114.52 | |
| Cytokinetics Com New (CYTK) | 3.2 | $69M | 2.1M | 32.62 | |
| ImmunoGen | 2.6 | $56M | 3.0M | 18.87 | |
| Karuna Therapeutics Ord | 2.5 | $54M | 250k | 216.85 | |
| Ideaya Biosciences (IDYA) | 2.4 | $52M | 2.2M | 23.50 | |
| Sage Therapeutics (SAGE) | 2.4 | $51M | 1.1M | 47.02 | |
| Nuvalent Inc-a (NUVL) | 2.4 | $51M | 1.2M | 42.17 | |
| Merus N V (MRUS) | 2.3 | $50M | 1.9M | 26.33 | |
| Amylyx Pharmaceuticals (AMLX) | 2.1 | $45M | 2.1M | 21.57 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.9 | $41M | 600k | 69.03 | |
| 89bio (ETNB) | 1.8 | $40M | 2.1M | 18.95 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $33M | 1.6M | 20.31 | |
| Iveric Bio | 1.5 | $33M | 825k | 39.34 | |
| Viking Therapeutics (VKTX) | 1.5 | $32M | 2.0M | 16.21 | |
| Argenx SE Sponsored Adr (ARGX) | 1.4 | $29M | 75k | 389.73 | |
| Amicus Therapeutics (FOLD) | 1.4 | $29M | 2.3M | 12.56 | |
| Rocket Pharmaceuticals (RCKT) | 1.4 | $29M | 1.5M | 19.87 | |
| Axsome Therapeutics (AXSM) | 1.3 | $29M | 400k | 71.86 | |
| Iteos Therapeutics | 1.3 | $29M | 2.2M | 13.24 | |
| Ventyx Biosciences (VTYX) | 1.3 | $28M | 850k | 32.80 | |
| Anaptysbio Inc Common (ANAB) | 1.2 | $26M | 1.3M | 20.34 | |
| Iovance Biotherapeutics (IOVA) | 1.2 | $26M | 3.7M | 7.04 | |
| Tango Therapeutics (TNGX) | 1.1 | $24M | 7.1M | 3.32 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $23M | 600k | 38.50 | |
| Madrigal Pharmaceuticals (MDGL) | 1.1 | $23M | 100k | 231.00 | |
| Relay Therapeutics (RLAY) | 1.1 | $23M | 1.8M | 12.56 | |
| Point Biopharma Global | 1.1 | $23M | 2.5M | 9.06 | |
| Exelixis (EXEL) | 1.0 | $22M | 1.2M | 19.11 | |
| Prothena Corp SHS (PRTA) | 0.9 | $21M | 300k | 68.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $20M | 3.2M | 6.26 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $15M | 1.7M | 9.00 | |
| Enliven Therapeutics (ELVN) | 0.7 | $15M | 711k | 20.41 | |
| Day One Biopharmaceuticals I (DAWN) | 0.7 | $14M | 1.2M | 11.94 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $13M | 1.7M | 7.76 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.6 | $13M | 450k | 28.21 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $12M | 1.1M | 11.09 | |
| Nurix Therapeutics (NRIX) | 0.6 | $12M | 1.2M | 9.99 | |
| Cullinan Oncology (CGEM) | 0.5 | $12M | 1.1M | 10.76 | |
| Prelude Therapeutics (PRLD) | 0.5 | $11M | 2.5M | 4.50 | |
| Black Diamond Therapeutics (BDTX) | 0.5 | $10M | 2.0M | 5.05 | |
| Geron Corporation (GERN) | 0.4 | $9.6M | 3.0M | 3.21 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 0.4 | $8.5M | 95k | 89.25 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $7.7M | 1.3M | 6.19 | |
| Cabaletta Bio (CABA) | 0.3 | $7.0M | 540k | 12.91 | |
| Cogent Biosciences (COGT) | 0.3 | $6.2M | 525k | 11.84 | |
| Disc Medicine (IRON) | 0.3 | $5.8M | 130k | 44.40 | |
| Rapt Therapeutics | 0.3 | $5.6M | 300k | 18.70 | |
| 2Seventy Bio Common Stock | 0.2 | $4.7M | 460k | 10.12 | |
| Gossamer Bio (GOSS) | 0.2 | $4.0M | 3.3M | 1.20 | |
| Selecta Biosciences | 0.2 | $3.7M | 3.3M | 1.12 | |
| Mersana Therapeutics | 0.2 | $3.3M | 1.0M | 3.29 | |
| Theseus Pharmaceuticals | 0.2 | $3.3M | 350k | 9.33 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $3.0M | 2.3M | 1.32 | |
| DBV Technologies S A Sponsored Adr | 0.1 | $2.8M | 1.5M | 1.90 | |
| Third Harmonic Bio (THRD) | 0.1 | $2.7M | 570k | 4.81 | |
| Fate Therapeutics (FATE) | 0.1 | $2.4M | 500k | 4.76 | |
| Atreca Cl A Com (BCEL) | 0.1 | $2.2M | 2.2M | 0.98 | |
| Bioatla (BCAB) | 0.1 | $2.1M | 686k | 3.00 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $2.0M | 699k | 2.85 | |
| Eqrx | 0.1 | $1.9M | 1.0M | 1.86 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.8M | 250k | 7.00 | |
| Kinnate Biopharma | 0.1 | $1.5M | 491k | 3.03 | |
| Rain Therapeutics | 0.1 | $1.4M | 1.2M | 1.20 | |
| Ngm Biopharmaceuticals | 0.1 | $1.3M | 500k | 2.59 | |
| MEI Pharma Com New | 0.0 | $958k | 146k | 6.58 | |
| ZIOPHARM Oncology | 0.0 | $765k | 1.5M | 0.51 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $500k | 209k | 2.39 | |
| Female Health (VERU) | 0.0 | $413k | 347k | 1.19 | |
| Bellicum Pharmaceuticals Com New | 0.0 | $167k | 450k | 0.37 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $44k | 267k | 0.17 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $4.0k | 67k | 0.06 |
